anti-CD20 CAR-T in vivo assay
We have successfully developed various animal models for the in vivo assay of anti-CD 20 CAR-T cell therapy. Immunodeficiency mice are injected intravenously, subcutaneously, or intraperitoneally with CD20+ cells, such as lymphoma cell lines, CD20 transfected cell lines, human primary lymphoma cells, as well as customized cell lines to build up a murine...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian